Sachs David C. bought IBRX
December 31, 2025 · Form 4 insider transaction
Sachs David C. bought 30,397 shares of ImmunityBio, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
30,397
Price
$0.00
Total value
N/A
InsiderSachs David C.
Role—
CompanyImmunityBio, Inc. (IBRX)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 31, 2025
Filing dateJanuary 5, 2026
Shares owned after256,017
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive one share of ImmunityBio, Inc. common stock.